Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 24.37B | 22.60B | 24.53B | 21.15B | 17.03B | 17.73B |
Gross Profit | 2.02B | 1.89B | 1.89B | 1.65B | 1.47B | 1.51B |
EBITDA | 654.50M | 665.73M | 690.13M | 870.71M | 344.63M | 395.48M |
Net Income | 495.37M | 491.91M | 484.56M | 578.64M | 237.77M | 255.94M |
Balance Sheet | ||||||
Total Assets | 16.82B | 16.82B | 14.80B | 14.48B | 14.61B | 15.00B |
Cash, Cash Equivalents and Short-Term Investments | 2.19B | 2.19B | 1.53B | 1.15B | 1.25B | 986.62M |
Total Debt | 600.00M | 600.00M | 650.00M | 706.35M | 699.54M | 713.30M |
Total Liabilities | 8.68B | 8.68B | 7.43B | 7.53B | 6.96B | 6.86B |
Stockholders Equity | 8.14B | 8.14B | 7.37B | 6.95B | 7.64B | 8.14B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 817.71M | 634.51M | -399.94M | 322.94M | -502.73M |
Operating Cash Flow | 0.00 | 818.26M | 644.57M | -398.37M | 324.82M | -472.18M |
Investing Cash Flow | 0.00 | -18.43M | -30.11M | 382.73M | 39.01M | 116.35M |
Financing Cash Flow | 0.00 | -172.14M | -269.32M | -62.48M | -77.02M | -547.29M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥5.85B | 9.68 | 5.03% | 8.52% | 14.08% | ||
71 Outperform | ¥7.35B | 8.06 | 1.94% | 19.43% | ― | ||
68 Neutral | ¥5.97B | 18.77 | 4.87% | 6.87% | 13.34% | ||
67 Neutral | ¥5.64B | 10.54 | 2.39% | 10.70% | 6.95% | ||
62 Neutral | $10.21B | 10.03 | -0.16% | 2.84% | 2.22% | -32.59% | |
60 Neutral | ¥7.61B | 15.07 | 1.47% | -0.49% | 137.27% | ||
55 Neutral | ¥7.98B | ― | ― | 20.71% | 0.54% |